Smith & Nephew SNATS, Inc. (NYSE:SNN - Get Free Report) has earned a consensus rating of "Hold" from the seven ratings firms that are covering the stock, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation. The average 12-month price objective among brokerages that have covered the stock in the last year is $36.00.
Several brokerages have recently issued reports on SNN. Canaccord Genuity Group upped their target price on shares of Smith & Nephew SNATS from $28.00 to $36.00 and gave the company a "hold" rating in a report on Monday, August 18th. Wall Street Zen cut shares of Smith & Nephew SNATS from a "strong-buy" rating to a "buy" rating in a research report on Friday. Finally, Weiss Ratings restated a "hold (c+)" rating on shares of Smith & Nephew SNATS in a research note on Saturday, September 27th.
Read Our Latest Research Report on SNN
Smith & Nephew SNATS Stock Performance
Shares of SNN opened at $35.94 on Tuesday. The company has a market capitalization of $15.65 billion, a price-to-earnings ratio of 16.64, a price-to-earnings-growth ratio of 1.00 and a beta of 0.69. Smith & Nephew SNATS has a 52-week low of $23.69 and a 52-week high of $38.79. The company has a quick ratio of 1.40, a current ratio of 3.00 and a debt-to-equity ratio of 0.60. The stock has a 50 day moving average price of $36.25 and a 200 day moving average price of $31.29.
Smith & Nephew SNATS Cuts Dividend
The company also recently announced a semi-annual dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 3rd will be given a $0.285 dividend. The ex-dividend date of this dividend is Friday, October 3rd. This represents a dividend yield of 165.0%. Smith & Nephew SNATS's dividend payout ratio is 26.39%.
Institutional Investors Weigh In On Smith & Nephew SNATS
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Bessemer Group Inc. boosted its holdings in shares of Smith & Nephew SNATS by 3,471.4% in the first quarter. Bessemer Group Inc. now owns 1,750 shares of the medical equipment provider's stock valued at $49,000 after acquiring an additional 1,701 shares during the period. Sequoia Financial Advisors LLC purchased a new stake in Smith & Nephew SNATS in the 1st quarter valued at $211,000. GAMMA Investing LLC boosted its stake in Smith & Nephew SNATS by 22.4% during the 1st quarter. GAMMA Investing LLC now owns 3,641 shares of the medical equipment provider's stock worth $103,000 after purchasing an additional 666 shares during the period. Oppenheimer Asset Management Inc. grew its position in Smith & Nephew SNATS by 37.7% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 53,590 shares of the medical equipment provider's stock worth $1,520,000 after purchasing an additional 14,677 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC acquired a new position in Smith & Nephew SNATS in the first quarter valued at $335,000. Hedge funds and other institutional investors own 25.64% of the company's stock.
About Smith & Nephew SNATS
(
Get Free Report)
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Smith & Nephew SNATS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew SNATS wasn't on the list.
While Smith & Nephew SNATS currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.